Search bioRxiv⌕ Search

Biology subjects

Korban, C.

Publications and source records attributed to Korban, C..

2 recordsLinked to original sources

Hybrid Transformer and Neural NetworkConfiguration for Protein Classification UsingAmino Acids

This study introduces a hybrid machine learning model for classifying proteins, developed to address the complexities of protein sequence and structural analysis. Utilizing an architecture that combines a lightweight transformer with a concurrent neural network, the hybrid model leverages both sequential and intrinsic physical properties of proteins. Trained on a comprehensive dataset from the Research Collaboratory for Structural Bioinformatics Protein Data Bank, the model demonstrates a classification accuracy of 95%, outperforming existing methods by at least 15%. The high accuracy achieved demonstrates the potential of this approach to innovate protein classification, facilitating advancements in drug discovery and the development of personalized medicine. By enabling precise protein function prediction, the hybrid model allows for specialized strategies in therapeutic targeting and the exploration of protein dynamics in biological systems. Future work will focus on enhancing the models generalizability across diverse datasets and exploring the integration of more machine learning techniques to refine predictive capabilities further. The implications of this research offer potential breakthroughs in biomedical research and the broader field of protein engineering.

bioengineering↗

Potential Opportunities of Modeling Bioavailability for Monoclonal Antibodies: An Overview of mAbs and the current challenges of mAb development

With a growing market size, and a large variety of applications, monoclonal antibody technology adoption and clinical usage is at an all-time high. This review article seeks to explore 10 monoclonal antibodies (mAbs) and their mechanism of action, specifically their pharmacodynamic (PD) and pharmacokinetic (PK) properties, and use a machine learning model with various parameters to assess whether the mAb has adequate bioavailability when delivered subcutaneously. This is an investigation of drug optimization and patient outcomes when transitioning from traditional IV administrations to subcutaneous injections. The machine learning model is an extension based on a paper by Han Lou and Michael Hageman, Machine Learning Attempts for Predicting Human Subcutaneous Bioavailability of Monoclonal Antibodies, where they took 10 mAbs and analyzed 45 different features. To further extend this paper, we took an additional 10 monoclonal antibodies that were delivered subcutaneously, and took into account their dosage concentration as an extension to traditional PK properties. By including additional mAbs and dosage, a more sophisticated model can be produced with high scalability to deep learning modalities.

bioengineering↗